Taprizosin free base
Code | Size | Price |
---|
TAR-T28922-5mg | 5mg | £790.00 | |||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
Special offer! Add £1 to your order to get a TargetMol CCK-8 Kit. Read more here. |
Quantity:
TAR-T28922-50mg | 50mg | £2,143.00 | |||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
Special offer! Add £1 to your order to get a TargetMol CCK-8 Kit. Read more here. |
Quantity:
TAR-T28922-100mg | 100mg | £2,801.00 | |||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
Special offer! Add £1 to your order to get a TargetMol CCK-8 Kit. Read more here. |
Quantity:
Prices exclude any Taxes / VAT
Overview
Regulatory Status: RUO
Shipping:
cool pack
Storage:
-20℃
Images
Documents
Further Information
Bioactivity:
Taprizosin, an alpha1A-adrenoceptor antagonist, is used potentially for the treatment of benign prostatic hyperplasia.
CAS:
210538-44-6
Formula:
C25H26N6O4S
Molecular Weight:
506.58
Purity:
0.98
SMILES:
COc1cc2nc(nc(N)c2c(-c2ccccn2)c1OC)N1CCc2c(C1)cccc2NS(C)(=O)=O
References
1. O'Rourke M, Kearns S, Docherty JR. Investigation of the actions of chloroethylclonidine in rat aorta. Br J Pharmacol. 1995 Aug;115(8):1399-406. PubMed PMID: 8564198; PubMed Central PMCID: PMC1908886.